Linkedin
See it in Action
Linkedin
See it in Action

“Proactive health management should be the new standard of care” – lifespin CEO Dr. Ali Tinazli on precision medicine

Precision medicine is changing how we think about healthcare. It is not only about treating disease but about understanding each person’s biology early enough to prevent illness before it begins. For Dr. Ali Tinazli, CEO of lifespin, this is more than a goal. It is a commitment to make personalized, preventive healthcare accessible to everyone.

MedTech World spoke with Dr. Tinazli about lifespin’s progress in metabolomics, its latest milestones, and why prevention should become the foundation of modern healthcare.

Read more

Follow us on LinkedIn
Back to News

More from press and media

New leadership team appointed at lifespin, strengthening go-to-market activities and accelerating growth

October 29, 2025
Regensburg, Germany – September 16, 2025 – lifespin GmbH, a frontrunner in personalized medical analysis based on metabolomics, announces the appointment of its new leadership ...
Read More

AI Blood Test Transforming the Future of Healthcare

September 24, 2025
Discover how lifespin is revolutionizing healthcare with an AI-powered blood test.With over 250,000 human metabolomic profiles and the ability to detect more than 700 diseases, ...
Read More

A “check engine light” for your health – featured in Mittelbayerische Zeitung

July 21, 2025
The German daily Mittelbayerische Zeitung highlights how lifespin is using AI and NMR-based blood analysis to detect diseases early – even before symptoms occur. In ...
Read More

How can we make advanced metabolomics accessible for routine clinical use — at an affordable cost — in service of the greater good of prevention and personalized medicine?

June 3, 2025
  Earlier this year at Arab Health in Dubai, Ali Tinazli spoke about our work at Lifespin GmbH and how our General Health Assessment (GHA) supports that goal. This ...
Read More

Metabolomics. Personalized diagnostics. A “check engine light” for your body.

June 3, 2025
You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share ...
Read More

Lifespin GmbH Awarded Major Grant from Bavarian Ministry for Economic Affairs for Groundbreaking OncoSpin Project

May 14, 2025
Regensburg, Germany – May 6, 2025 – Lifespin GmbH, a frontrunner in personalized medical solutions, announces securing a grant from Bavarian Ministery for Economic Affairs ...
Read More

Lifespin GmbH and HS Weihenstephan-Triesdorf Awarded Grant from Bayerische Forschungsstiftung for Pioneering Deep Health Initiative

May 9, 2025
Regensburg, Germany – May 9, 2025 – Lifespin GmbH, a leader in personalized healthcare innovation, together with Hochschule Weihenstephan-Triesdorf (HSWT), is pleased to announce the ...
Read More

Lifespin GmbH and Premier Integrated Labs

March 31, 2025
In a significant step towards advancing preventive and personalized medicine, lifespin GmbH has partnered with Premier Integrated Labs (PIL) to introduce AI-powered metabolomic testing in ...
Read More
Scroll to Top
video-thumb

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.
  • Background in medicinal chemistry
  • Built and headed the life sciences department at numares AG
  • Pioneered NMR-based metabolic profiling
  • Successfully implemented 30+ R&D projects for analytical methods, software and systems

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.
  • Background in Biophysics, computer sciences and NMR. Several patents in this field.
  • Member of the board of lipofit GmbH and numares AG. Establishing internationalization.
  • Co-founded lifespin GmbH in 2017. Setting up company structures.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.
  • Plasma physics, MPI Garching
  • In 2004 he co-founded LipoFIT GmbH, served as its manager, transforming it into numares AG—growing the company into an international operation
  • Co-founded lifespin GmbH in 2017

Dr. Ali Tinazli

CEO, lifespin GmbH
Linkedin Envelope

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

  • Built HP’s global healthcare strategy
  • Commercialized first IVD product for billionaire-funded Fluxergy
  • Board member (e.g. Edico Genome acquired by Illumina)